238 related articles for article (PubMed ID: 32474095)
21. Visual Field Mean Deviation at Diagnosis of Idiopathic Intracranial Hypertension Predicts Visual Outcome.
Mikkilineni S; Trobe JD; Cornblath WT; De Lott L
J Neuroophthalmol; 2019 Jun; 39(2):186-190. PubMed ID: 30153119
[TBL] [Abstract][Full Text] [Related]
22. Intracranial idiopathic hypertension: 1-year follow-up study.
D'Amico D; Curone M; Erbetta A; Farago' G; Bianchi-Marzoli S; Ciasca P; Bussone G; Chiapparini L
Neurol Sci; 2014 May; 35 Suppl 1():177-9. PubMed ID: 24867861
[TBL] [Abstract][Full Text] [Related]
23. Chronic daily headache with migrainous features due to papilledema-negative idiopathic intracranial hypertension.
Huff AL; Hupp SL; Rothrock JF
Cephalalgia; 1996 Oct; 16(6):451-2. PubMed ID: 8902257
[TBL] [Abstract][Full Text] [Related]
24. Is cerebrospinal fluid shunting in idiopathic intracranial hypertension worthwhile? A 10-year review.
Sinclair AJ; Kuruvath S; Sen D; Nightingale PG; Burdon MA; Flint G
Cephalalgia; 2011 Dec; 31(16):1627-33. PubMed ID: 21968519
[TBL] [Abstract][Full Text] [Related]
25. Benign Intracranial Hypertension -Is it Really Benign Always?
Ganger A; Kumar NK; Kumar P; Sabharwal RK; Khosla A; Saxena R
Nepal J Ophthalmol; 2018 Jan; 10(19):102-106. PubMed ID: 31056586
[TBL] [Abstract][Full Text] [Related]
26. Lumboperitoneal and Ventriculoperitoneal Shunting for Idiopathic Intracranial Hypertension Demonstrate Comparable Failure and Complication Rates.
Azad TD; Zhang Y; Varshneya K; Veeravagu A; Ratliff JK; Li G
Neurosurgery; 2020 Feb; 86(2):272-280. PubMed ID: 30937428
[TBL] [Abstract][Full Text] [Related]
27. Comparative Study of the Effectiveness of Lumboperitoneal and Ventriculoperitoneal Shunting with Neuronavigation in the Treatment of Idiopathic Intracranial Hypertension.
de Oliveira AJM; Pinto FCG; Teixeira MJ
Neurol India; 2020; 68(5):1061-1064. PubMed ID: 33109853
[TBL] [Abstract][Full Text] [Related]
28. Frameless stereotactic ventricular shunt placement for idiopathic intracranial hypertension.
Woodworth GF; McGirt MJ; Elfert P; Sciubba DM; Rigamonti D
Stereotact Funct Neurosurg; 2005; 83(1):12-6. PubMed ID: 15724109
[TBL] [Abstract][Full Text] [Related]
29. Cerebrospinal fluid shunt placement for pseudotumor cerebri-associated intractable headache: predictors of treatment response and an analysis of long-term outcomes.
McGirt MJ; Woodworth G; Thomas G; Miller N; Williams M; Rigamonti D
J Neurosurg; 2004 Oct; 101(4):627-32. PubMed ID: 15481717
[TBL] [Abstract][Full Text] [Related]
30. Asymptomatic idiopathic intracranial hypertension in young children.
Weig SG
J Child Neurol; 2002 Mar; 17(3):239-41. PubMed ID: 12026246
[TBL] [Abstract][Full Text] [Related]
31. Optic disc haemorrhages at baseline as a risk factor for poor outcome in the Idiopathic Intracranial Hypertension Treatment Trial.
Wall M; Thurtell MJ;
Br J Ophthalmol; 2017 Sep; 101(9):1256-1260. PubMed ID: 28130349
[TBL] [Abstract][Full Text] [Related]
32. [Characteristic neurological features, differential diagnostic criteria and medicinal treatment of idiopathic intracranial hypertension].
Willenborg KD; Nacimiento W
Ophthalmologe; 2015 Oct; 112(10):814-20. PubMed ID: 26377103
[TBL] [Abstract][Full Text] [Related]
33. Outcomes of ventriculoperitoneal shunt insertion in the management of idiopathic intracranial hypertension in children.
Heyman J; Ved R; Amato-Watkins A; Bhatti I; Te Water Naude J; Gibbon F; Leach P
Childs Nerv Syst; 2017 Aug; 33(8):1309-1315. PubMed ID: 28536838
[TBL] [Abstract][Full Text] [Related]
34. Quality of life at 6 months in the Idiopathic Intracranial Hypertension Treatment Trial.
Bruce BB; Digre KB; McDermott MP; Schron EB; Wall M;
Neurology; 2016 Nov; 87(18):1871-1877. PubMed ID: 27694262
[TBL] [Abstract][Full Text] [Related]
35. Lumbo-peritoneal shunt as treatment modality for visual symptoms in idiopathic intracranial hypertension: A single institution experience.
Krishnan SS; Nigam P; Manuel A; Vasudevan MC
Neurocirugia (Astur : Engl Ed); 2021; 32(2):53-61. PubMed ID: 32482535
[TBL] [Abstract][Full Text] [Related]
36. Management of idiopathic intracranial hypertension with a programmable lumboperitoneal shunt: Early experience.
Alkherayf F; Abou Al-Shaar H; Awad M
Clin Neurol Neurosurg; 2015 Sep; 136():5-9. PubMed ID: 26056804
[TBL] [Abstract][Full Text] [Related]
37. A comparison of lumboperitoneal and ventriculoperitoneal shunting for idiopathic intracranial hypertension: an analysis of economic impact and complications using the Nationwide Inpatient Sample.
Menger RP; Connor DE; Thakur JD; Sonig A; Smith E; Guthikonda B; Nanda A
Neurosurg Focus; 2014 Nov; 37(5):E4. PubMed ID: 25363432
[TBL] [Abstract][Full Text] [Related]
38. Weight reduction for a better visual outcome in idiopathic intracranial hypertension.
Koc F; Isik MR; Sefi-Yurdakul N
Arq Bras Oftalmol; 2018; 81(1):18-23. PubMed ID: 29538589
[TBL] [Abstract][Full Text] [Related]
39. The Use of Endoscopic Third Ventriculostomy as Treatment for Idiopathic Intracranial Hypertension: Case Report and a Review of Previously Reported Cases.
Trenchfield D; Di L; Shah A; Desai D; Gudoor P; Eichberg DG; Luther EM; Komotar RJ
World Neurosurg; 2020 Sep; 141():373-376. PubMed ID: 32634635
[TBL] [Abstract][Full Text] [Related]
40. Coexistence of migraine and idiopathic intracranial hypertension without papilledema.
Mathew NT; Ravishankar K; Sanin LC
Neurology; 1996 May; 46(5):1226-30. PubMed ID: 8628457
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
